Read More Pharma Industry News Marksans Pharma secures US FDA approval for multiple strengths of Pregabalin capsules in key neuropathic pain segment Marksans Pharma wins US FDA approval for multi-strength Pregabalin capsules, targeting a USD 263M neuropathic pain market in the United States. bySrinathJuly 21, 2022